Upper gastrointestinal bleeding and COVID-19 – A tertiary care centre experience

PTU-29 Table 1Odds ratio of mortality OR 95% CI p Age 1.05 1.04-1.07 <0.001 Male 1.20 0.89-1.61 0.232 Upper GI Bleed 1.03 0.48-2.15 0.947 Hb 0.99 0.99-1.00 0.139 Heart Rate 1.02 1.01-1.02 <0.001 Urea 1.05 1.03-1.07 <0.001 Systolic BP 0.99 0.99-1.00 0.200 BMI 0.99 0.97-1.01 0.476 OR: odds ratio;CI: confidence interval.ConclusionsThe incidence of concurrent UGIB in patients with COVID-19 infection is low and our data suggests that UGIB does not increase the mortality rate in patients with COVID-19 but does increase LOS. Endoscopic intervention did not appear to affect mortality or LOS. Although numbers are small, this data suggests selection criteria used for endoscopy was justified.ReferenceMauro A, et al. Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy. Clin Res Hepatol Gastroenterol 2020.